Apollo Hospitals Enterprise Limited vs Strides Pharma Science Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Strides Pharma Science Limited (STAR) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Strides Pharma Science Limited leads APOLLOHOSP vs STAR on 7 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability13
  • Growth10
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

STAR takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
17.60
13.46
P/B ratio
3.61
0.22%
Dividend yield
0.41%
₹135.04
EPS
₹60.34

Profitability

STAR takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
17.90%
17.31%
Return on capital
17.74%
14.94%
EBITDA margin
19.04%
7.94%
Net margin
11.82%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
9.62%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹9,624 Cr
₹25,229 Cr
Revenue
₹4,859 Cr
₹2,003 Cr
Net profit
₹575 Cr
0.90
Debt / equity
0.54
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Strides Pharma Science Limited
  • + ["Company has delivered good profit growth of 17.4% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 56.6%"]
  • − ["The company has delivered a poor sales growth of 7.9% over past five years."]
Apollo Hospitals Enterprise Limited full analysis Strides Pharma Science Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.